Companies / CAAM
CAAM
United States
CaaMTech is a pharmaceutical drug discovery company utilizing a collaborative scientific approach to engineering novel small-molecule therapeutics.
CAAM, based in United States, has 2 investors on file, among them Kortschak Investments and Noetic Fund. Its site was last checked 13 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Kortschak Investments
32 companies on its checked portfolioIts portfolio leans to Enterprise Software (16%), AI & Machine Learning (14%), E-commerce & Marketplaces (10%).
See Kortschak Investments' full profile · Who invests alongside it
More from Noetic Fund
20 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (90%), Education (5%), AI & Machine Learning (5%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get CAAM and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Kortschak Investments adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/caam.tech/investors
# also
GET /v1/companies/caam.tech
GET /v1/companies/caam.tech/news